During the past decade, Institute for Treatment and Rehabilitation Niska Banja conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 16 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute for Treatment and Rehabilitation Niska Banja" #1 sponsor was "Pfizer" with 8 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Treatment and Rehabilitation Niska Banja" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Treatment and Rehabilitation Niska Banja" are "Rheumatoid Arthritis" (11 trials), "Lupus Erythematosus, Systemic" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Institute for Treatment and Rehabilitation Niska Banja" in a lesser frequency.

Most popular intervention types in "Institute for Treatment and Rehabilitation Niska Banja" are "Drug" (21 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Adalimumab" (2 trials), "BI 695501" (2 trials), "Baricitinib" (2 trials) and "GDC-0853" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Treatment and Rehabilitation Niska Banja" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Treatment and Rehabilitation Niska Banja". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Institute for Treatment and Rehabilitation Niska Banja, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Treatment and Rehabilitation Niska Banja, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Institute for Treatment and Rehabilitation Niska Banja has several departments that took part in Clinical trials: "Institute of Rheumatology and Cardiovascular Diseases; Rheumatology" - 3 trials, "Institute of Rheumatology Niska Banja" - 2 trials